SNM collaboration yields diagnostic nuclear medicine guide for compliance with NRC regulations

October 30, 2002

Reston, VA....The Society of Nuclear Medicine (SNM) announced today the release of a unique, one-stop reference work for diagnostic nuclear medicine professionals who want to bring their departments and institutions into compliance with recently revised federal regulations governing the medical use of byproduct material. Guide for Diagnostic Nuclear Medicine, published by the SNM and authored by Jeffry A. Siegel, PhD, represents the first major joint effort between the Nuclear Regulatory Commission (NRC; Bethesda, MD) and a stakeholder organization whose members' professional practices are regulated by NRC rules.

The new NRC regulations under 10 CFR Part 35 (Medical Use of Byproduct Material) became effective October 24, 2002, and govern the medical use and licensing of byproduct materials across the spectrum of diagnostic practice. The revised rule is intended to be less prescriptive than the current rule. The most significant change, according to Siegel, is "a new emphasis on risk-informed, performance-based approaches that focus not on procedures but on outcomes." Since the first use of nuclear medicine in the United States in the 1940s, more than one-third of a billion doses have been administered to patients, with unparalleled safety and almost no adverse events. In structuring the new regulations, the NRC took this low risk into account by eliminating or decreasing the prescriptiveness of the regulations that apply to diagnostic nuclear medicine. Instead, the NRC is relying on a performance-based approach that emphasizes not a step-by-step adherence to "best practices" but a consistent level of performance outcomes by institutions at which nuclear medicine is practiced.

"With this changed focus, we knew that it would be useful for practitioners to have a stand-alone document that suggests appropriate operating policies and sample procedures for compliance with the revised Part 35 and with other NRC regulations," says Siegel, who is chair of the Joint Government Relations Committee of the SNM and the American College of Nuclear Physicians. Working closely with representatives from the NRC, Siegel compiled this useful resource that covers all pertinent regulations, addresses compliance concerns and standards, and provides operating policies and procedures and "At a Glance" and summary features. "The book is intended to serve as a useful bridge between the new regulations and nuclear medicine practitioners who want to ensure continued compliance and thereby maintain the security and safe use of licensed materials in clinical and research settings," says Siegel.

The NRC released a separate guidance volume on October 20 as Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses (NUREG-1556, Volume 9; available at www.nrc.gov). This guidance is intended to outline one means of acceptable compliance but is not intended to be the only means of satisfying the new requirements. Because most nuclear medicine departments do not have the resources to develop custom operating procedures, the NRC guidance is often followed. The SNM volume offers, for the first time, alternate guidance devised by nuclear medicine professionals specifically for the needs of nuclear medicine departments. "We believed that it was important to create guidance that directly addressed the detailed information that diagnostic nuclear medicine professionals would need to know in practicing under the new regulations," says Siegel. The SNM book includes chapters on training and experience, the license application process, license amendment and renewal, and a detailed chapter that offers a point-by-point guide to setting up and implementing an effective radiation protection program.

"For all diagnostic nuclear medicine practitioners, the primary and paramount focus remains on the accurate, timely, and safe diagnosis of illness and disease," says Siegel. Compliance with changing federal regulations and increased familiarity with the implications of these regulations will assure both practitioners and patients of adequate and effective radiation safety practices. The SNM is currently consulting with NRC staff on the preparation of a companion Guide to Therapeutic Nuclear Medicine, to be published in 2003.
-end-
The Society of Nuclear Medicine is an international scientific and professional organization with more than 14,000 members dedicated to promoting the science, technology, and practical applications of nuclear medicine

The Guide for Diagnostic Nuclear Medicine is available from the SNM at www.snm.org via the on line Service Center (click on Shop SNM). The SNM is currently working with the NRC to make the document freely available to the nuclear medicine community.

Society of Nuclear Medicine

Related Nuclear Medicine Articles from Brightsurf:

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Story tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine
ORNL Story Tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine.

Global nuclear medicine community shares COVID-19 strategies and experiences
In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine.

Influence of the Journal of Nuclear Medicine jumps 25%
The Journal of Nuclear Medicine again ranks among the top 5 medical imaging journals in the world.

Nuclear medicine PSMA-targeted study offers new options for cancer theranostics worldwide
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a fresh perspective on cancer imaging and radioligand therapy (theranostics).

Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome.

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging
A nuclear medicine imaging procedure can pinpoint prostate cancer with superior accuracy, allowing more precisely targeted treatment, according to new research featured in the November 2018 issue of The Journal of Nuclear Medicine.

New nuclear medicine tracer will help study the aging brain
A new PET imaging radiotracer could help researchers understand neurodegenerative disease and the aging brain.

New nuclear medicine imaging method shows strong potential for cancer imaging
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

New nuclear medicine technique could help tackle brain disease
A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

Read More: Nuclear Medicine News and Nuclear Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.